
Anti-TGFb1 antibody (Y123162) by ABM is a mouse monoclonal IgG1 targeting recombinant human TGF-β1 fragment aa/1-111, validated for Western blot at 1:1000 and ELISA. Supplied as 100 μg/100 μl affinity-purified liquid. Available through MBP, a registered vendor for Howard Hughes Medical Institute, Vanderbilt University, MD Anderson Cancer Center, and Eurofins, among other prominent institutes across the USA.